Page 507 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 507

Chapter 33







                     REFERENCES

                       1. Cohn JN. Blood pressure measurement in shock. Mechanism     14. Ruokonen E, Parviainen I, Uusaro A. Treatment of impaired
                        of inaccuracy in ausculatory and palpatory methods.  JAMA.   perfusion in septic shock. Ann Med. 2002;34(7-8):590-597.
                        1967;199(13):118-122.                                15. Annane D, Vignon P, Renault A, et al. Norepinephrine plus
                       2. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis   dobutamine versus epinephrine alone for management of septic
                        Campaign: international guidelines for management of severe   shock: a randomised trial. Lancet. 2007;370(9588):676-684.
                        sepsis and septic shock: 2008. Crit Care Med. 2008;36(1):296-327.    16. De Backer D, Biston P, Devriendt J, et al. Comparison of dopa-
                       3. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy   mine and norepinephrine in the treatment of shock. N Engl J
                        in the treatment of severe sepsis and septic shock. N Engl J Med.   Med. 2010;362(9):779-789.
                        2001;345(19):1368-1377.                              17. Myburgh JA, Higgins A, Jovanovska A, Lipman J,
                       4. Menon V, Hochman JS. Management of cardiogenic shock   Ramakrishnan N, Santamaria J. A comparison of epinephrine
                        complicating acute myocardial infarction.  Heart. 2002;88(5):   and norepinephrine in critically ill patients. Intensive Care Med.
                        531-537.                                                2008;34(12):2226-2234.
                       5. Grassino A, Macklem PT. Respiratory muscle fatigue and venti-    18. Russell JA, Walley KR, Singer J, et al. Vasopressin versus norepi-
                        latory failure. Annu Rev Med. 1984;35:625-647.          nephrine infusion in patients with septic shock. N Engl J Med.
                       6. Hussain SN, Roussos C. Distribution of respiratory muscle   2008;358(9):877-887.
                        and organ blood flow during endotoxic shock in dogs. J Appl     19. Gordon AC, Russell JA, Walley KR, et al. The effects of vaso-
                        Physiol. 1985;59(6):1802-1808.                          pressin on acute kidney injury in septic shock. Intensive Care
                       7. Del Sorbo L, Slutsky AS. Ventilatory support for acute respi-  Med. 2010;36(1):83-91.
                        ratory  failure:  new  and  ongoing  pathophysiological,  diag-    20. Walley KR. Use of central venous oxygen saturation to guide
                        nostic and therapeutic developments.  Curr Opin Crit Care.   therapy. Am J Respir Crit Care Med. 2010;184(5):514-520.
                        2010;16(1):1-7.                                      21. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for
                       8. The Acute Respiratory Distress Syndrome Network. Ventilation   patients with septic shock. N Engl J Med. 2008;358(2):111-124.
                        with lower tidal volumes as compared with traditional tidal     22. Annane D, Sebille V, Charpentier C, et al. Effect of treatment
                        volumes for acute lung injury and the acute respiratory distress   with low doses of hydrocortisone and fludrocortisone on mor-
                        syndrome. N Engl J Med. 2000;342(18):1301-1308.         tality in patients with septic shock. JAMA. 2002;288(7):862-871.
                       9. Reynolds HR, Hochman JS. Cardiogenic shock: current concepts     23. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid
                        and improving outcomes. Circulation. 2008;117(5):686-697.  on  death,  vascular  occlusive  events,  and  blood  transfusion  in
                      10. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA,   trauma patients with significant haemorrhage (CRASH-2): a ran-
                        Kline  JA.  Lactate  clearance  vs  central  venous  oxygen  satura-  domised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
                        tion as goals of early sepsis therapy: a randomized clinical trial.     24. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension
                        JAMA. 2010;303(8):739-746.                              before initiation of effective antimicrobial therapy is the critical
                      11. de Guzman E, Shankar MN, Mattox KL. Limited volume resus-  determinant of survival in human septic shock. Crit Care Med.
                        citation in penetrating thoracoabdominal trauma. AACN Clin   2006;34(6):1589-1596.
                        Issues. 1999;10(1):61-68.                            25. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety
                      12. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, ran-  of recombinant human activated protein C for severe sepsis.
                        domized, controlled clinical trial of transfusion requirements   N Engl J Med. 2001;344(10):699-709.
                        in critical care. Transfusion Requirements in Critical Care     26. Michard F, Boussat S, Chemla D, et al. Relation between respira-
                        Investigators, Canadian Critical Care Trials Group.  N Engl J   tory changes in arterial pulse pressure and fluid responsiveness
                        Med. 1999;340(6):409-417.                               in septic patients with acute circulatory failure. Am J Respir Crit
                      13. Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus   Care Med. 2000;162(1):134-138.
                        delayed fluid resuscitation for hypotensive patients with pen-    27. Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness
                        etrating torso injuries. N Engl J Med. 1994;331(17):1105-1109.  of right heart catheterization in the initial care of   critically









            Section03-O-ref.indd   1                                                                                   1/20/2015   7:10:21 AM
   502   503   504   505   506   507   508   509   510   511   512